In the past few decades “Publish or perish” has become a norm in scientific research. On the other hand, scholarly communication is stunned by commercial publishing companies and so is academia with publishing.
We are in the middle of the Biorevolution. Recombinant DNA technology is used to “program cells” to make important things like medicine, industrial products, and food.
According to National Science Foundation, 4000 new papers are published within the scientific community every day and the number of annual publications has increased from 1 million in 2000 to more than 2 million in 2013.
The genomics market is rapidly growing and expected to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020. The growth of the overall market has resulted in the increasing number of start-up companies
In the last few decades, scientific research has enormously changed from performing experiments in a single lab to a dynamic collaborative environment with multiple research labs.
Modern healthcare is moving towards precision medicine rather than traditional one-size-fits-all approach. Recent advancements in technology are making this trend much faster than it was happening.
As per the OECD survey, US produces at least twice as many Ph.D. graduates compared Germany. According to the data around 67,449 graduated with a Ph.D. in 2014 from the US compared to 28,147 from Germany followed by UK, India, and Japan.
an Israeli company has developed technology to make the water from the air we breathe. Water-gen is focused on developing innovative technology for water supply and air drying solutions.
Diploid is a Leuven-based genomics start-up that aims to revolutionize healthcare by bringing genome diagnostics into daily clinical practice. Peter Schols, CEO of Diploid, founded the company in 2014 out of his passion for both software development and genetics.
Financial technology, or most commonly known as FinTech, is a business made up of companies that adopt latest technology and innovation with existing resources in order to contest in the marketplace of traditional financial establishments and mediators in the delivery of financial services.
Kevin Tsai recently graduated from the Ph.D. program in Bioinformatics at Academia Sinica, Taiwan. Prior to graduating, he did contract work with McKinsey & Co. and held positions at Gilead Sciences and Celera.
Internet is huge! Help us find great content
Never miss a thing! Sign up for our newsletter to stay updated.
Research Stash is a curated collection of tools and News for S.T.E.M researchers
Have any questions or want to partner with us? Reach us at hello@researchstash.com
